NYSE - Delayed Quote USD
AbbVie Inc. (ABBV)
188.09
+0.94
+(0.50%)
At close: May 7 at 4:00:02 PM EDT
185.56
-2.53
(-1.35%)
Pre-Market: 4:05:43 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 26 | 26 |
| Avg. Estimate | 3.17 | 3.21 | 12.23 | 13.95 |
| Low Estimate | 2.87 | 3.02 | 11.96 | 12.94 |
| High Estimate | 3.29 | 3.38 | 12.7 | 15.08 |
| Year Ago EPS | 2.65 | 3 | 10.12 | 12.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 21 | 26 |
| Avg. Estimate | 14.93B | 15.34B | 59.91B | 64.58B |
| Low Estimate | 14.56B | 15.07B | 59.41B | 61.62B |
| High Estimate | 15.18B | 15.71B | 60.85B | 67.18B |
| Year Ago Sales | 14.46B | 14.46B | 56.33B | 59.91B |
| Sales Growth (year/est) | 3.27% | 6.12% | 6.36% | 7.78% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 2.66 | 2.92 | 2.12 | 2.4 |
| EPS Actual | 2.65 | 3 | 2.16 | 2.46 |
| Difference | -0.01 | 0.08 | 0.04 | 0.06 |
| Surprise % | -0.39% | 2.82% | 1.92% | 2.63% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 3.17 | 3.21 | 12.23 | 13.95 |
| 7 Days Ago | 3.05 | 3.26 | 12.23 | 13.94 |
| 30 Days Ago | 3.09 | 3.23 | 12.29 | 13.9 |
| 60 Days Ago | 3.09 | 3.23 | 12.27 | 13.81 |
| 90 Days Ago | 3.11 | 3.22 | 12.26 | 13.84 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 11 | 4 | 15 | 13 |
| Up Last 30 Days | 7 | 6 | 7 | 14 |
| Down Last 7 Days | -- | 4 | 4 | 5 |
| Down Last 30 Days | 4 | 5 | 13 | 7 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABBV | 19.80% | 7.02% | 20.80% | 14.08% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 4/29/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 4/28/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/28/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 4/22/2025 |
| Reiterates | Guggenheim: Buy to Buy | 4/17/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/9/2025 |
Related Tickers
JNJ Johnson & Johnson
157.30
+1.83%
MRK Merck & Co., Inc.
79.12
+0.10%
BMY Bristol-Myers Squibb Company
47.62
+0.11%
AMGN Amgen Inc.
275.84
+2.00%
PFE Pfizer Inc.
22.79
-0.39%
LLY Eli Lilly and Company
776.72
+0.21%
GILD Gilead Sciences, Inc.
98.90
+1.04%
NVO Novo Nordisk A/S
67.55
+1.90%
OGN Organon & Co.
8.76
-4.05%
AZN AstraZeneca PLC
70.07
-0.27%